CSPC PHARMACEUTICAL GROUP LIMITED (01093) released its monthly return on movements in securities for February 2026. The announcement shows that the total number of issued ordinary shares remained at 11.52 billion, with no treasury shares reported. The public float requirement continues to be met at a threshold of 25%.

Under the 2015 Share Option Scheme, 1.30 million share options remained outstanding and exercisable as of the end of February 2026. No shares were issued or transferred under this scheme during the month. No convertibles, warrants, or any other arrangements to issue shares were recorded.

The latest report confirms no changes in share capital or treasury shares for the period.